These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12519227)

  • 1. Prediction of relapse after interferon therapy in hepatitis C virus-infected patients by the use of triple assay.
    El-Awady MK; Abdel Rahman MM; Ismail SM; Amr KS; Omran M; Mohamed SA
    J Gastroenterol Hepatol; 2003 Jan; 18(1):68-73. PubMed ID: 12519227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of interferon in combination with ribavirin on the plus and minus strands of hepatitis C virus RNA in patients with hepatitis].
    He Y; Liu W; Zeng L
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):32-5. PubMed ID: 9275644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
    Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse.
    Gerotto M; Dal Pero F; Bortoletto G; Ferrari A; Pistis R; Sebastiani G; Fagiuoli S; Realdon S; Alberti A
    J Hepatol; 2006 Jan; 44(1):83-7. PubMed ID: 16271794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of hepatitis C virus RNA in peripheral blood mononuclear cells during therapy with interferon-alpha2a.
    Moonka DK; Henzel BS; Gutekunst K; O'Brien CB
    J Viral Hepat; 1998 Jan; 5(1):27-33. PubMed ID: 9493514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of relapses after interferon-alpha therapy by hepatitis C virus RNA in peripheral blood mononuclear cells.
    Kusaka S; Okusa T; Araki A; Fujiki K; Takashimizu I; Okayasu I; Yamamoto N; Sato C
    J Med Virol; 1995 Jul; 46(3):265-8. PubMed ID: 7561801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
    Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV RNA in peripheral blood cell subsets in HCV-HIV coinfected patients at the end of PegIFN/RBV treatment is associated with virologic relapse.
    de Felipe B; Leal M; Soriano-Sarabia N; Gutiérrez A; López-Cortés L; Molina-Pinelo S; Vallejo A
    J Viral Hepat; 2009 Jan; 16(1):21-7. PubMed ID: 18761604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.
    Chemello L; Cavalletto L; Casarin C; Bonetti P; Bernardinello E; Pontisso P; Donada C; Belussi F; Martinelli S; Alberti A
    Ann Intern Med; 1996 Jun; 124(12):1058-60. PubMed ID: 8633819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
    Schmidt WN; Wu P; Brashear D; Klinzman D; Phillips MJ; LaBrecque DR; Stapleton JT
    Hepatology; 1998 Oct; 28(4):1110-6. PubMed ID: 9755250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA.
    Muratori L; Giostra F; Cataleta M; Francesconi R; Ballardini G; Cassani F; Lenzi M; Bianchi FB
    Liver; 1994 Jun; 14(3):124-8. PubMed ID: 8078391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes of hepatitis C virus in relapsed and non-respondent patients and their response to anti-viral therapy in district Mardan, Khyber Pakhtunkhawa, Pakistan.
    Akhtar N; Bilal M; Rizwan M; Khan MA; Khan A
    Asian Pac J Cancer Prev; 2015; 16(3):1037-40. PubMed ID: 25735327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment.
    Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J
    Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.
    Marcellin P; Boyer N; Gervais A; Martinot M; Pouteau M; Castelnau C; Kilani A; Areias J; Auperin A; Benhamou JP; Degott C; Erlinger S
    Ann Intern Med; 1997 Nov; 127(10):875-81. PubMed ID: 9382365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
    Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
    Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells in patients with chronic hepatitis C treated with interferon alpha.
    Basaras M; de las Heras B; García Bengoechea M; Gallego L; Arrese E; Cisterna R
    Eur J Clin Microbiol Infect Dis; 1996 Nov; 15(11):887-90. PubMed ID: 8997566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of HCV RNA in peripheral blood mononuclear cells may predict patients response to interferon and ribavirin therapy.
    Zaman N; Asad MJ; Raza A; Raja GK; Akhter S; Mahmood M; Mahmood RT
    Ann Saudi Med; 2014; 34(5):401-6. PubMed ID: 25827697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
    Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
    N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of genomic- and minus-strand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction.
    Negro F; Krawczynski K; Quadri R; Rubbia-Brandt L; Mondelli M; Zarski JP; Hadengue A
    Hepatology; 1999 Feb; 29(2):536-42. PubMed ID: 9918932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.